Vaxart Market Cap

Vaxart has a market cap or net worth of $177.30 million as of March 6, 2026. Its market cap has increased by 10.56% in one year.

Market Cap

177.30M

Enterprise Value

167.47M

Revenue

148.20M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.74

Market Cap Chart

Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 177.30M, an increase of 193.79%. That is a compound annual growth rate of 14.31%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	177.30M	113.29%
Dec 31, 2025	83.13M	-44.81%
Dec 31, 2024	150.61M	72.95%
Dec 29, 2023	87.09M	-30.95%
Dec 30, 2022	126.12M	-83.97%
Dec 31, 2021	786.86M	25.88%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silence Therapeutics	273.01M
CytoDyn	310.14M
BioStem Technologies	97.20M
Northwest Biotherapeutics	354.92M
HST Global	70.56M
Nuo Therapeutics	67.60M
Vicapsys Life Sciences	48.56M
Cell Source	41.50M

Market Cap Rankings